ReviewClinical reviews in allergy & immunology2008
Diagnosis of cystic fibrosis.
Review in Clinical reviews in allergy & immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 45 citations in OpenAlex.
- Effect of malnutrition in infants with cystic fibrosis in India: An underestimated danger.Journal of family medicine and primary care · 2021Article
- Screening for the Most Common Mutations ofJournal of pediatric genetics · 2020Article
- Article
- A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.International journal of respiratory and pulmonary medicine · 2018Article
- Mutation spectrum of Egyptian children with cystic fibrosis.SpringerPlus · 2016Article
- Analysis of Cystic Fibrosis in Federation of Bosnia and Herzegovina.Medical archives (Sarajevo, Bosnia and Herzegovina) · 2015Article
- A new method to improve the clinical evaluation of cystic fibrosis patients by mucus viscoelastic properties.PloS one · 2014Article
- Surgical treatment of non-cystic fibrosis bronchiectasis in Brazilian children.Pediatric surgery international · 2014Article
- Atypical cystic fibrosis: identification in the primary care setting.Canadian family physician Medecin de famille canadien · 2012Review
- Diagnostic tools in Rhinology EAACI position paper.Clinical and translational allergy · 2011Article
- A tailored approach to family-centered genetic counseling for cystic fibrosis newborn screening: the Wisconsin model.Journal of genetic counseling · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene that results in abnormal viscous mucoid secretions in multiple organs and whose main clinical features are pancreatic insufficiency and chronic endobronchial infection. Although it was initially defined and diagnosed based on clinical features and sweat chloride measurement, an in vivo method of assessing CFTR function, the discovery of the CFTR gene in 1989 revealed a broad spectrum of CF phenotypes associated with specific CFTR gene mutations. In this article, we will review the indications for sweat testing, alternative techniques to diagnose CF, and the approach to patients with an ambiguous or indeterminate diagnosis of CF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.